{"prompt": "['24.', 'Morgan SG, Hunt J, Rioux J, Proulx J, Weymann D, Tannenbaum C. Frequency and cost', 'of potentially inappropriate prescribing for older adults: a cross-sectional study. CMAJ', 'Open. 2016;4(2):E346-351.', '25.', 'Canadian Deprescribing Network: Deprescribing algorithms. 2017;', '//www.deprescribingnetwork.ca/algorithms/.', '26.', 'Choosing Wisely Canada Geriatrics. 2017; https://choosingwiselycanada.org/geriatrics/', '27.', 'Pollock K, Grime J. The cost and cost-effectiveness of PPIs--GP perspectives and', 'responses to a prescribing dilemma and their implications for the development of patient-', 'centred healthcare. Eur J Gen Pract. 2003;9(4):126-133, 140.', '28.', 'Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors. Canadian', 'Family Physician. 2017;63(5):354.', '29.', 'Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Zolpidem use and hip fractures in', 'older people. J Am Geriatr Soc. 2001;49(12):1685-1690', '30.', 'Tannenbaum C, Farrell B, Shaw J, et al. An Ecological Approach to Reducing Potentially', 'Inappropriate Medication Use: Canadian Deprescribing Network. Can J Aging.', '2017;36(1):97-107.', '31.', 'Hogan DB, Maxwell CJ, Fung TS, Ebly EM. Prevalence and potential consequences of', 'benzodiazepine use in senior citizens: results from the Canadian Study of Health and', 'Aging. Can J Clin Pharmacol. 2003;10(2):72-77.', '32.', 'Wang PS, Schneeweiss S, Avorn J, et al. Risk of Death in Elderly Users of Conventional', 'VS. Atypical Antipsychotic Medications. New England Journal of Medicine.', '2005;353(22):2335-2341.', '33.', 'Steinberg M, Lyketsos CG. ATYPICAL ANTIPSYCHOTIC USE IN PATIENTS WITH', 'DEMENTIA: MANAGING SAFETY CONCERNS. The American journal of psychiatry.', '2012;169(9):900-906.', '34.', 'Reeve E, Ong M, Wu A, Jansen J, Petrovic M, Gnjidic D. A systematic review of', 'interventions to deprescribe benzodiazepines and other hypnotics among older people.', 'Eur J Clin Pharmacol. 2017;73(8):927-935.', '35.', 'Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of', 'inappropriate benzodiazepine prescriptions among older adults through direct patient', 'education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890-', '898.', '36.', 'Garfinkel D, Ilhan B, Bahat G. Routine deprescribing of chronic medications to combat', 'polypharmacy. Ther Adv Drug Saf. 2015;6(6):212-233.', '37.', 'Thompson W, Hogel M, LiY, et al. Effect of a Proton Pump Inhibitor Deprescribing', 'Guideline on Drug Usage and Costs in Long-Term Care. J Am Med Dir Assoc.', '2016;17(7):673.e671-674.', '38.', 'Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and', 'effect of deprescribing in older adults on mortality and health: a systematic review and', 'meta-analysis. Br J Clin Pharmacol. 2016;82(3):583-623.', '39.', 'Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in', 'people aged 65 years and older: a systematic review. Drugs Aging. 2008;25(12): 1021-', '1031.', '40.', 'Jansen J, Naganathan V, Carter SM, et al. Too much medicine in older people?', 'Deprescribing through shared decision making. Bmj. 2016;353:i2893.', '41.', 'Boulin M, Diaby V, Tannenbaum C. Preventing Unnecessary Costs of Drug-Induced', 'Hypoglycemia in Older Adults with Type 2 Diabetes in the United States and Canada.', 'PLoS One. 2016;11(9):e0162951.', '42.', 'Farrell B, Black C, Thompson W, et al. Deprescribing antihyperglycemic agents in older', 'persons: Evidence-based clinical practice guideline. Can Fam Physician.', '2017;63(11):832-843.', '43.', 'Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and', 'management on adverse drug reactions and suboptimal prescribing in the frail elderly.', 'Am J Med. 2004;116(6):394-401.', '44.', 'Spinewine A, Swine C, Dhillon S, et al. Effect of a collaborative approach on the quality', 'of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc.', '2007;55(5):658-665.', '45.', 'Herxheimer A, McGettigan P. Problems of polypharmacy. Bmj. 2013;347:f7500.', '46.', 'Frank C, Weir E. Deprescribing for older patients. Cmaj. 2014;186(18):1369-1376.', '47.', 'Lenander C, Elfsson B, Danielsson B, Midlov P, Hasselstrom J. Effects of a pharmacist-', 'led structured medication review in primary care on drug-related problems and hospital', '78 Page']['admission rates: a randomized controlled trial. Scand J Prim Health Care.', '2014;32(4):180-186.', '48.', 'Bokhof B, Junius-Walker U. Reducing Polypharmacy from the Perspectives of General', 'Practitioners and Older Patients: A Synthesis of Qualitative Studies. Drugs Aging.', '2016;33(4):249-266.', '49.', 'Birtwhistle R, Keshavjee K, Lambert-Lanning A, et al. Building a pan-Canadian primary', 'care sentinel surveillance network: initial development and moving forward. J Am Board', 'Fam Med. 2009;22(4):412-422.', '50.', 'Mold JW, Peterson KA. Primary care practice-based research networks: working at the', 'interface between research and quality improvement. Ann Fam Med. 2005;3 Suppl 1:S12-', '20.', '51.', 'Donner A. Some aspects of the design and analysis of cluster randomization trials. Appl', 'Stat. 1998;47:95-113.', '52.', 'Schwartz D, Lellouch J. Explanatory and pragmatic issues in clinical trials. J of Chronic', 'Diseases. 1967(20):637-648.', '53.', 'Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmatic-explanatory continuum', 'indicator summary (PRECIS): a tool to help trial designers. CMAJ. 2009;180(10):E47-57', '54.', 'Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J', 'Chronic Dis. 1967;20(8):637-648.', '55.', 'Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT', 'statement to randomized trials of nonpharmacologic treatment: explanation and', 'elaboration. Ann Intern Med. 2008;148(4):295-309.', '56.', 'Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statement: extension', 'to cluster randomised trials. Bmj. 2012;345:e5661.', '57.', 'Romanow R. Building on values: the future of health care in Canada. Ottawa2002.', '58.', 'Brehaut JC, Colquhoun HL, Eva KW, et al. Practice Feedback Interventions: 15', 'Suggestions for Optimizing Effectiveness. Ann Intern Med. 2016.', '59.', 'Linsky A, Simon SR, Stolzmann K, Meterko M. Patient Perceptions of Deprescribing:', 'Survey Development and Psychometric Assessment. Med Care. 2017;55(3):306-313.', '60.', 'Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and', 'enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793-807.', '61.', 'Turner JP, Edwards S, Stanners M, Shakib S, Bell JS. What factors are important for', 'deprescribing in Australian long-term care facilities? Perspectives of residents and health', 'professionals. BMJ Open. 2016;6(3):e009781', '62.', 'Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an', 'overview of reviews and development of a theoretical framework. BMC Health Serv Res.', '2017;17(1):88', '63.', 'Montiel-Luque A, Nunez-Montenegro AJ, Martin-Aurioles E, Canca-Sanchez JC, Toro-', 'Toro MC, Gonzalez-Correa JA. Medication-related factors associated with health-related', 'quality of life in patients older than 65 years with polypharmacy. PLoS One.', '2017;12(2):e0171320.', '64.', 'Clement S. The self-efficacy expectations and occupational preferences of females and', 'males. Journal of Occupational Psychology. 1987;60(3):257-265.', '65.', 'Rosella LC, Fitzpatrick T, Wodchis WP, Calzavara A, Manson H, Goel V. High-cost', 'health care users in Ontario, Canada: demographic, socio-economic, and health status', 'characteristics. BMC Health Serv Res. 2014;14:532.', '66.', 'Wodchis W, Bushmeneva K, Nikitovi\u00e9 M, McKillop IH, McKillop E. Guidelines on', 'Person-level Costing Using Administrative Databases in Ontario. Working Paper Series.', 'Vol 1. 2013.', '67.', 'Wodchis WP, Austin PC, Henry DA. A 3-year study of high-cost users of health care.', 'CMAJ. 2016;188(3):182-188.', '68.', 'MacCarthy D, Kallstrom L, Kadlec H, Hollander M. Improving primary care in British', 'Columbia, Canada: evaluation of a peer-to-peer continuing education program for family', 'physicians. BMC Med Educ. 2012;12:110.', '69.', 'Farrell B, Richardson L, Raman-Wilms L, de Launay D, Alsabbagh MW, Conklin J.', 'Self-efficacy for deprescribing: A survey for health care professionals using evidence-', 'based deprescribing guidelines. Res Social Adm Pharm. 2017.', '70.', 'WHO Collaborating Centre for drug statistic methodology - ATC/DDD Index. 2017;', 'https://www.whocc.no/atc ddd index/.', '71.', 'Green LA, White LL, Barry HC, Nease DE, Jr, Hudson BL. Infrastructure Requirements', 'for Practice-Based Research Networks. Ann Fam Med. 2005;3(suppl 1):S5-11.', '79', 'Page']\n\n###\n\n", "completion": "END"}